Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN -3.01% slid 7.37% to $8.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.04% falling 0.35% to 4,685.25 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.38% falling 0.31% to 36,319.98. This was the stock's second consecutive day of losses. Ocugen Inc. closed $9.85 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +0.16% rose 1.32% to $2.30, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +1.89% rose 7.46% to $7.63, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +1.30% fell 3.31% to $117.78. Trading volume (31.4 M) remained 4.8 million below its 50-day average volume of 36.2 M.